DiaSorin has launched a molecular assay for the rapid detection and quantification of cytomegalovirus (CMV). The DiaSorin Iam CMV assay is used to detect and quantify clinically relevant subtypes of CMV in human plasma, urine and cerebrospinal fluid (CSF), making it suitable for the diagnosis and monitoring of CMV infection in transplant recipients and other immunocompromised individuals.
The assay has good intra-run precision (≤0.3 log cps/mL) and diagnostic sensitivity (≥97%) and specificity (100%) said to be comparable to conventional PCR, but with results in a fraction of the time. In addition to being used for the detection and monitoring of CMV infection in immunocompromised individuals, the product is also used in the diagnosis of maternal and foetal CMV infection in early pregnancy and for monitoring CMV infection in affected babies. It is CE marked in accordance to IVD Medical Device Directive 98/79 CE.
Based on DiaSorin Q-LAMP technology, Iam CMV is the latest infectious disease assay for use on the DiaSorin Liaison Iam analyser. The small footprint, ease of use and scalable design of the benchtop instrument make it suitable for use in laboratory facilities of all sizes, including those that are located close to the patient.
Phone: 02 9338 4888
ALA Scientific Instruments RuFus cell unroofing system for plasma membrane isolation
ALA Scientific Instruments offers RuFus, a complete and user-friendly system for performing cell...
Lonza plateable mouse hepatocytes
Lonza provides plateable mouse hepatocytes from the four most common research mouse strains,...
PEPperPRINT cLIFT peptide microarray platform
At the core of the technology is a laser-based transfer process that is designed to deposit amino...
